07 January 2019 | News
The Company is hopeful to generate revenue from its CBD Gum, during the latter part of this current operating Quarter.
image credit- theheartysoul.com
Tauriga Sciences, Inc., engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, has announced that the Company has entered into a comprehensive manufacturing agreement with a Maryland based Gum Manufacturer for the production of its Cannabis/CBD chewing gum product line (CBD Gum).
The Agreement is effective as of December 28, 2018 and the Company has already paid a substantial portion of the costs pertaining to the initial production run; 8,700 units (each unit contains 8 pieces of CBD Gum).
The Company has been meeting with a number of potential distributors over the past 2 months and is pleased with the feedback provided. Additionally, the Company has built its CBD Gum product line, specifically implementing the advice that several of these prospective distributors have offered to management. The Company is hopeful to generate revenue from its CBD Gum, during the latter part of this current operating Quarter (period: January 1, 2019 – March 31, 2019); Tauriga’s 4th Fiscal Quarter of 2019.